Safety considerations: breastfeeding after transplant

Area of Science:

• Transplantation Medicine
• Neonatal Health
• Immunology

Background:

• Organ transplantation restores function for end-stage organ failure, enabling pregnancy in women.
• Post-transplant pregnancies are feasible across various organ types, with stable graft function reliant on immunosuppression.
• Neonatal outcomes in transplant recipients often include prematurity and low birth weight.

Purpose of the Study:

• To review the benefits of breastfeeding for infants born to organ transplant recipients.
• To examine common immunosuppressive agents and their excretion into breast milk.
• To summarize existing data and provide recommendations on breastfeeding for immunosuppressed mothers.

Main Methods:

• Literature review of case reports, center reports, and registry data.
• Analysis of studies on breastfeeding in organ transplant recipients.
• Examination of immunosuppressive agents and their potential effects on infants via breast milk.

Main Results:

• Breastfeeding offers documented emotional, nutritional, and immunologic benefits for newborns.
• Concerns exist regarding infant exposure to immunosuppressive drugs through breast milk.
• Some transplant recipients have chosen to breastfeed despite professional concerns.

Conclusions:

• Breastfeeding post-transplant requires careful risk-benefit assessment regarding immunosuppressant exposure.
• Further studies are essential to determine safe levels of drug exposure for infants.
• Guidance is needed for healthcare professionals to support informed breastfeeding decisions for mothers on immunosuppressive therapy.